Precigen, Inc. (PGEN) vs uniQure N.V. (QURE)
- Precigen, Inc. PGEN 4.43 +4.98%
- uniQure N.V. QURE 21.62 +2.90%
Precigen, Inc. and uniQure N.V. are both Biotechnology companies. Precigen, Inc. and uniQure N.V. are of similar size ($1.5B and $1.5B). uniQure N.V. has negative trailing earnings, so its P/E is not meaningful; Precigen, Inc. trades at 60.3×. Precigen, Inc. grew revenue faster over the last twelve months: 2,387.6% against 28.0%. Precigen, Inc. has the higher net margin (15.6% vs −1,154.8%) and the higher return on invested capital (15.9% vs 0.00%). Across the 18 metrics below, Precigen, Inc. leads on 12 and uniQure N.V. on 6.
Valuation
Profitability
| Metric | PGEN | QURE | Biotechnology median |
|---|---|---|---|
| Gross margin | 91.42% | 93.85% | 68.51% |
| Operating margin | 21.43% | (1,001.74%) | 0.00% |
| Net margin | 15.55% | (1,154.84%) | 0.00% |
| Free cash flow margin | (47.35%) | (956.80%) | 0.00% |
| Return on equity | 38.84% | (88.99%) | (51.96%) |
| Return on assets | 12.73% | (25.47%) | (46.06%) |
| Return on invested capital | 15.93% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack